![Simon Kerry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Kerry
Directeur Général chez
Curve Therapeutics Ltd.
Profil
Simon Kerry is the founder of Curve Therapeutics Ltd., founded in 2019, where the title held is Chief Executive Officer.
Dr. Kerry is also the founder of Isogenica Ltd...
Dr. Kerry is currently Chairman at Argonaut Therapeutics Ltd. Former positions include Chief Executive Officer at Karus Therapeutics Ltd. from 2006 to 2011, Director-Business Development at Active Biotech AB, Director-Business Development at Ablynx NV, Principal at Health Protection Agency, Principal at Actinova Ltd., Principal at Actigen Ltd., and Operating Partner at Advent Venture Partners LLP.
Education includes an undergraduate degree (1984), a doctorate (1989), and an MBA (1995) from Loughborough University.
Postes actifs de Simon Kerry
| Sociétés | Poste | Début |
|---|---|---|
Argonaut Therapeutics Ltd.
 Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Président | - |
Curve Therapeutics Ltd.
 Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company which engages in development of technologies to address undruggable diseases | Directeur Général | 01/07/2019 |
Anciens postes connus de Simon Kerry
| Sociétés | Poste | Fin |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | - |
Actigen Ltd.
 Actigen Ltd. BiotechnologyHealth Technology Provides biological products | Corporate Officer/Principal | - |
Health Protection Agency
 Health Protection Agency General GovernmentGovernment Governmental department | Corporate Officer/Principal | - |
Actinova Ltd.
 Actinova Ltd. Pharmaceuticals: MajorHealth Technology Provides research and development services to the biotechonolgy sectors and also develops drugs and vaccines | Corporate Officer/Principal | - |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Fondateur | - |
Formation de Simon Kerry
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Health Protection Agency
Health Protection Agency General GovernmentGovernment Governmental department | Government |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Provides therapies for treatment of cancer and inflammatory diseases | Health Technology |
Loughborough University
 Loughborough University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Actinova Ltd.
Actinova Ltd. Pharmaceuticals: MajorHealth Technology Provides research and development services to the biotechonolgy sectors and also develops drugs and vaccines | Health Technology |
Actigen Ltd.
Actigen Ltd. BiotechnologyHealth Technology Provides biological products | Health Technology |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Health Technology |
Curve Therapeutics Ltd.
Curve Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company which engages in development of technologies to address undruggable diseases | Commercial Services |
